M G Fakih Selected Research

Capecitabine (Xeloda)

6/2006

Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M G Fakih Research Topics

Disease

2	Infections 04/2015 - 01/2009
2	Colorectal Neoplasms (Colorectal Cancer) 04/2012 - 03/2012
1	Colonic Neoplasms (Colon Cancer) 02/2010
1	Neoplasm Metastasis (Metastasis) 02/2010
1	Adenocarcinoma 06/2006
1	Bacteremia 03/2006

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 04/2015 - 03/2006
2	Vancomycin FDA LinkGeneric 01/2009 - 03/2006
1	Cholecalciferol (Vitamin D3)FDA Link 04/2012
1	Vorinostat FDA Link 03/2012
1	Fluorouracil (Carac)FDA LinkGeneric 03/2012
1	Capecitabine (Xeloda)FDA Link 06/2006
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2006
1	beta-LactamsIBA 03/2006
1	Methicillin (Metin)FDA Link 03/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 04/2012 - 02/2010
1	Therapeutics 04/2015
1	Hepatectomy 02/2010
1	Radiotherapy 06/2006
1	Neoadjuvant Therapy 06/2006